Chemoinformaics analysis of 2-(methoxymethyl)aniline
Molecular Weight | 137.182 | nRot | 2 |
Heavy Atom Molecular Weight | 126.094 | nRig | 6 |
Exact Molecular Weight | 137.084 | nRing | 1 |
Solubility: LogS | -0.818 | nHRing | 0 |
Solubility: LogP | 0.982 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 22.5967 |
nHD | 1 | BPOL | 12.2013 |
QED | 0.625 |
Synth | 1.715 |
Natural Product Likeliness | -0.277 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.956 |
HIA | 0.003 |
CACO-2 | -4.403 |
MDCK | 0.0000781 |
BBB | 0.347 |
PPB | 0.215257 |
VDSS | 1.346 |
FU | 0.684906 |
CYP1A2-inh | 0.3 |
CYP1A2-sub | 0.423 |
CYP2c19-inh | 0.204 |
CYP2c19-sub | 0.837 |
CYP2c9-inh | 0.037 |
CYP2c9-sub | 0.08 |
CYP2d6-inh | 0.103 |
CYP2d6-sub | 0.866 |
CYP3a4-inh | 0.03 |
CYP3a4-sub | 0.343 |
CL | 6.785 |
T12 | 0.619 |
hERG | 0.036 |
Ames | 0.889 |
ROA | 0.566 |
SkinSen | 0.863 |
Carcinogencity | 0.796 |
EI | 0.99 |
Respiratory | 0.299 |
NR-Aromatase | 0.038 |
Antiviral | No |
Prediction | 0.908481 |